GRI Bio (NASDAQ:GRI) (NASDAQ: GRI) is a biotechnology company focused on leveraging advanced algae strains to address global environmental and health challenges. Founded in the United States, the company applies proprietary gene-editing and synthetic biology techniques to enhance microalgae’s natural capabilities for use in carbon capture, water purification, and the production of high-value bioproducts. By engineering algae with improved growth rates and metabolic efficiency, GRI Bio aims to deliver scalable solutions that contribute to climate mitigation and sustainable manufacturing.
The company’s core offerings span several key areas. In environmental applications, GRI Bio develops algae-based systems for capturing and sequestering industrial carbon emissions and for treating wastewater by removing nutrients and pollutants. In the bioproducts arena, the firm produces specialty proteins, lipids, and pigments for use in animal feed, nutraceuticals, and cosmetics. Through collaborations with industrial partners, GRI Bio is working to integrate its algae-derived materials into existing supply chains, providing renewable alternatives to petrochemical- and soy-based ingredients.
Headquartered in Cambridge, Massachusetts, GRI Bio operates research and development facilities in multiple states and maintains partnerships with academic institutions and industrial consortia around the world. Its team of molecular biologists, bioprocess engineers, and sustainability experts works closely with commercial stakeholders to pilot and scale technologies in North America, Europe, and Asia. Strategic alliances have enabled the company to demonstrate its algae platforms under diverse environmental conditions and accelerate regulatory approvals for novel bio-based products.
The company’s leadership team combines expertise in biotechnology, business development, and environmental policy. Guided by a board of directors with deep experience in life sciences and clean-tech investment, GRI Bio pursues a roadmap that balances scientific innovation with market-driven applications. Through ongoing research collaborations and capital partnerships, the company seeks to expand its portfolio of algae-enabled solutions and contribute to a more sustainable, bio-based economy.
